跳转至内容
Merck
CN

SRP0363

Cot active mouse

recombinant, expressed in baculovirus infected Sf9 cells, ≥50% (SDS-PAGE)

别名:

Cot, Map3k8, Tpl2, mitogen-activated protein kinase kinase kinase 8

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.32
UNSPSC Code:
12352202
Assay:
≥50% (SDS-PAGE)
Biological source:
mouse
Recombinant:
expressed in baculovirus infected Sf9 cells
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Cot active mouse, recombinant, expressed in baculovirus infected Sf9 cells, ≥50% (SDS-PAGE)

biological source

mouse

recombinant

expressed in baculovirus infected Sf9 cells

assay

≥50% (SDS-PAGE)

form

aqueous solution

mol wt

70 kDa

packaging

pkg of 10 μg

NCBI accession no.

UniProt accession no.

shipped in

dry ice

storage temp.

−70°C

Gene Information

mouse ... MAP3K8(26410)

General description

Mouse Cot kinase (MAP3K8) (GenBank Accession No. NM_007746), amino acids 30-397 with N-terminal His-GST-tag, expressed in a Baculovirus infected Sf9 cell expression system.

Physical form

Formulated in 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.4 mM KCl, 5 mM glutathione, 134 mM imidazole, 3 mM DTT and 20% glycerol.

pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Repr. 1B

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Joseph H Jeong et al.
PloS one, 6(1), e16205-e16205 (2011-01-27)
Despite its initial positive response to hormone ablation therapy, prostate cancers invariably recur in more aggressive, treatment resistant forms. The lack of our understanding of underlying genetic alterations for the transition from androgen-dependent (AD) to ADI prostate cancer growth hampers
Irene Soria-Castro et al.
The Journal of biological chemistry, 285(44), 33805-33815 (2010-08-26)
Cot/tpl2 (also known as MAP3K8) has emerged as a new and potentially interesting therapeutic anti-inflammatory target. Here, we report the first study of Cot/tpl2 involvement in acute peripheral inflammation in vivo. Six hours after an intraplantar injection of zymosan, Cot/tpl2(-/-)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持